Tebipenem
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Tebipenem
Description :
Tebipenem is an orally available carbapenem antibiotic, shows broad-spectrum activity against Gram-positive and -negative bacteria, except for Pseudomonas aeruginosa.Product Name Alternative :
LJC 11036UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
Antibiotic; BacterialType :
Reference compoundRelated Pathways :
Anti-infectionApplications :
COVID-19-immunoregulationField of Research :
InfectionAssay Protocol :
https://www.medchemexpress.com/Tebipenem.htmlPurity :
99.69Solubility :
DMSO : 33.33 mg/mL (ultrasonic) |H2O : 5.83 mg/mL (ultrasonic; warming; heat to 60°C)Smiles :
O=C(C(N1C2=O)=C(SC3CN(C4=NCCS4)C3)[C@H](C)[C@]1([H])[C@@]2([H])[C@H](O)C)OMolecular Formula :
C16H21N3O4S2Molecular Weight :
383.49Precautions :
H302, H315, H319, H335References & Citations :
[1]Hazra S, et al. Tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the β-lactamase from Mycobacterium tuberculosis. Biochemistry. 2014 Jun 10;53 (22) :3671-8|[2]Seenama C, et al. In vitro activity of tebipenem against Burkholderia pseudomallei. Int J Antimicrob Agents. 2013 Oct;42 (4) :375.|[3]Li H, et al. In vitro antibacterial activities of two novel oral antibiotics, tebipenem and cefditoren, and other comparators against community-acquired respiratory tract infection-associated bacterial pathogens: A multicentre study in China. Int J Antimicrob Agents. 2014 Jan;43 (1) :92-3.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
Phase 3Isoform :
β-lactamCAS Number :
[161715-21-5]

